Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-10

Clinical Trial Update: Targin® for Chronic Pain Management in Patients With Spinal Cord Injury [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Targin in chronic pain management following spinal cord injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TARGIN (oxycodone/naloxone)

Snippet

Sponsor: University of British Columbia | Conditions: Chronic Pain | Phase 4 | Status: COMPLETED